Our objective at Onxeo is to maintain an open, rich dialogue with our shareholders, our potential investors and the financial community at large. We keep you informed on a regular basis of the progress made by the Company in order to help you with your analysis and make it easier for you to understand the Company’s added value.

Agenda >

BioMed Event

December 19, 2017

Guggenheim Securities 5th Annual Boston Healthcare Conference 2017

December 13, 2017

Q3 results and business update

October 26, 2017

Portzamparc Biotech Symposium

October 19, 2017

Large & MidCap Forum

October 4-5, 2017